Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Macromolecular Substances | 4 | 2017 | 1435 | 1.040 |
Why?
|
Complement Activation | 3 | 2022 | 447 | 0.960 |
Why?
|
Complement System Proteins | 3 | 2022 | 738 | 0.850 |
Why?
|
Allergy and Immunology | 1 | 2024 | 175 | 0.820 |
Why?
|
Lupus Nephritis | 2 | 2024 | 327 | 0.780 |
Why?
|
Complement Pathway, Alternative | 1 | 2021 | 113 | 0.720 |
Why?
|
Complement C3 | 2 | 2020 | 434 | 0.630 |
Why?
|
Extracellular Matrix | 6 | 2017 | 1739 | 0.620 |
Why?
|
Pemphigus | 2 | 2010 | 107 | 0.600 |
Why?
|
Lupus Erythematosus, Systemic | 4 | 2024 | 2171 | 0.600 |
Why?
|
Lung Injury | 1 | 2021 | 433 | 0.530 |
Why?
|
Fibroblasts | 6 | 2017 | 4179 | 0.490 |
Why?
|
Dermis | 1 | 2016 | 203 | 0.480 |
Why?
|
Th1 Cells | 3 | 2009 | 1042 | 0.470 |
Why?
|
Th2 Cells | 3 | 2009 | 1079 | 0.450 |
Why?
|
Tissue Engineering | 6 | 2016 | 1893 | 0.420 |
Why?
|
Iridoids | 1 | 2012 | 18 | 0.410 |
Why?
|
Ficoll | 1 | 2012 | 39 | 0.410 |
Why?
|
Keratin-19 | 1 | 2011 | 33 | 0.380 |
Why?
|
Collagen | 4 | 2016 | 2646 | 0.370 |
Why?
|
Oxygen | 3 | 2017 | 4272 | 0.350 |
Why?
|
Erythrocytes | 1 | 2020 | 2421 | 0.350 |
Why?
|
Regenerative Medicine | 1 | 2014 | 311 | 0.350 |
Why?
|
Reperfusion Injury | 1 | 2016 | 1036 | 0.340 |
Why?
|
Cytokines | 6 | 2023 | 7453 | 0.330 |
Why?
|
Urinary Bladder Neoplasms | 3 | 2011 | 2251 | 0.330 |
Why?
|
Blotting, Western | 2 | 2016 | 5033 | 0.280 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2517 | 0.270 |
Why?
|
Tissue Scaffolds | 2 | 2015 | 951 | 0.260 |
Why?
|
ADAM Proteins | 2 | 2024 | 243 | 0.260 |
Why?
|
Pityriasis Rubra Pilaris | 1 | 2024 | 20 | 0.230 |
Why?
|
Antioxidants | 5 | 2011 | 1673 | 0.230 |
Why?
|
Disintegrins | 1 | 2024 | 27 | 0.230 |
Why?
|
Antigens, Neoplasm | 1 | 2011 | 2001 | 0.210 |
Why?
|
Immunohistochemistry | 4 | 2021 | 11116 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.210 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2024 | 299 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.200 |
Why?
|
Osteogenesis | 2 | 2023 | 1295 | 0.200 |
Why?
|
Lipid Peroxidation | 4 | 2011 | 276 | 0.190 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 3813 | 0.190 |
Why?
|
Complement Inactivating Agents | 1 | 2021 | 53 | 0.180 |
Why?
|
Epithelial Cells | 2 | 2024 | 3702 | 0.180 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 642 | 0.180 |
Why?
|
Arthritis, Experimental | 1 | 2023 | 293 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8749 | 0.170 |
Why?
|
Oxidants | 2 | 2011 | 168 | 0.170 |
Why?
|
Lectins | 1 | 2022 | 490 | 0.170 |
Why?
|
Complement Membrane Attack Complex | 1 | 2020 | 105 | 0.170 |
Why?
|
Keratinocytes | 1 | 2024 | 876 | 0.170 |
Why?
|
Interleukin-1beta | 1 | 2024 | 1026 | 0.150 |
Why?
|
History, 21st Century | 1 | 2024 | 1575 | 0.150 |
Why?
|
Interleukin-2 | 1 | 2024 | 1895 | 0.140 |
Why?
|
Fibrosis | 1 | 2024 | 2080 | 0.140 |
Why?
|
Matrix Metalloproteinases | 2 | 2017 | 393 | 0.140 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2016 | 1731 | 0.140 |
Why?
|
Mucin-1 | 1 | 2021 | 539 | 0.130 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2258 | 0.130 |
Why?
|
Densitometry | 1 | 2016 | 151 | 0.130 |
Why?
|
Microscopy, Phase-Contrast | 2 | 2015 | 110 | 0.130 |
Why?
|
History, 20th Century | 1 | 2024 | 2771 | 0.130 |
Why?
|
Virus Diseases | 1 | 2022 | 724 | 0.130 |
Why?
|
Caco-2 Cells | 1 | 2016 | 367 | 0.130 |
Why?
|
Cathepsins | 1 | 2016 | 242 | 0.130 |
Why?
|
Cell Shape | 1 | 2016 | 371 | 0.120 |
Why?
|
Matrix Metalloproteinase 2 | 2 | 2015 | 462 | 0.120 |
Why?
|
Cell Membrane | 1 | 2024 | 3659 | 0.120 |
Why?
|
Organogenesis | 1 | 2016 | 214 | 0.120 |
Why?
|
Malondialdehyde | 3 | 2009 | 113 | 0.120 |
Why?
|
Calcium | 2 | 2024 | 5792 | 0.110 |
Why?
|
Humans | 35 | 2024 | 768970 | 0.110 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2012 | 2044 | 0.110 |
Why?
|
Corneal Stroma | 1 | 2015 | 166 | 0.110 |
Why?
|
Acrylic Resins | 1 | 2014 | 135 | 0.110 |
Why?
|
Membrane Proteins | 3 | 2024 | 7885 | 0.110 |
Why?
|
India | 5 | 2012 | 2334 | 0.110 |
Why?
|
Dextran Sulfate | 1 | 2014 | 258 | 0.100 |
Why?
|
Glutaral | 1 | 2012 | 78 | 0.100 |
Why?
|
Cornea | 2 | 2017 | 1315 | 0.100 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 2 | 2023 | 75 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4413 | 0.100 |
Why?
|
Ascorbic Acid | 3 | 2009 | 658 | 0.090 |
Why?
|
Nitric Oxide | 1 | 2020 | 2149 | 0.090 |
Why?
|
Up-Regulation | 3 | 2024 | 4148 | 0.090 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2012 | 271 | 0.090 |
Why?
|
Cells, Cultured | 5 | 2017 | 19023 | 0.090 |
Why?
|
Dermatitis, Contact | 1 | 2010 | 134 | 0.090 |
Why?
|
Oxidative Stress | 4 | 2010 | 3139 | 0.090 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2012 | 416 | 0.080 |
Why?
|
Achilles Tendon | 1 | 2012 | 181 | 0.080 |
Why?
|
Desmoglein 3 | 1 | 2009 | 9 | 0.080 |
Why?
|
Cross-Linking Reagents | 1 | 2012 | 692 | 0.080 |
Why?
|
Cell Line | 2 | 2014 | 15604 | 0.080 |
Why?
|
Tongue Neoplasms | 1 | 2011 | 186 | 0.080 |
Why?
|
Middle Aged | 14 | 2024 | 223737 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2016 | 2414 | 0.080 |
Why?
|
Muscle Neoplasms | 1 | 2009 | 130 | 0.080 |
Why?
|
Vitiligo | 1 | 2009 | 97 | 0.080 |
Why?
|
Female | 20 | 2024 | 397515 | 0.070 |
Why?
|
Aged | 8 | 2021 | 171786 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6086 | 0.070 |
Why?
|
Pre-Eclampsia | 2 | 2007 | 1255 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2024 | 627 | 0.070 |
Why?
|
Stress, Mechanical | 1 | 2012 | 1680 | 0.070 |
Why?
|
Plant Extracts | 1 | 2010 | 499 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10276 | 0.070 |
Why?
|
Interleukin-10 | 2 | 2009 | 1183 | 0.070 |
Why?
|
Kidney | 1 | 2021 | 7058 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2016 | 1672 | 0.060 |
Why?
|
Cell Adhesion | 1 | 2012 | 3102 | 0.060 |
Why?
|
Drug Discovery | 1 | 2013 | 1068 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 977 | 0.060 |
Why?
|
Interleukin-4 | 1 | 2009 | 1157 | 0.060 |
Why?
|
Vitamin E | 1 | 2009 | 874 | 0.060 |
Why?
|
Male | 13 | 2024 | 365203 | 0.060 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2024 | 158 | 0.060 |
Why?
|
Phospholipase C gamma | 1 | 2024 | 131 | 0.060 |
Why?
|
Microscopy, Atomic Force | 2 | 2015 | 250 | 0.060 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2024 | 86 | 0.060 |
Why?
|
Cell Differentiation | 5 | 2024 | 11684 | 0.060 |
Why?
|
Adult | 12 | 2024 | 223851 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2012 | 1943 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2017 | 10486 | 0.060 |
Why?
|
Biocompatible Materials | 1 | 2012 | 1703 | 0.050 |
Why?
|
Guanylate Cyclase | 1 | 2024 | 206 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2024 | 739 | 0.050 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2024 | 165 | 0.050 |
Why?
|
Culture Media | 2 | 2015 | 898 | 0.050 |
Why?
|
Animals | 8 | 2024 | 169335 | 0.050 |
Why?
|
Kidney Tubules | 1 | 2024 | 454 | 0.050 |
Why?
|
Lung | 1 | 2021 | 10099 | 0.050 |
Why?
|
Case-Control Studies | 5 | 2012 | 22296 | 0.050 |
Why?
|
Swine | 1 | 2012 | 5997 | 0.050 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2009 | 799 | 0.050 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3629 | 0.050 |
Why?
|
Mice | 4 | 2024 | 82072 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2024 | 1251 | 0.040 |
Why?
|
Skin Diseases | 1 | 2009 | 1085 | 0.040 |
Why?
|
Leptin | 1 | 2007 | 1597 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 59739 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22379 | 0.040 |
Why?
|
Carcinoma | 1 | 2009 | 2340 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18354 | 0.040 |
Why?
|
Actins | 1 | 2024 | 2065 | 0.030 |
Why?
|
Cell Culture Techniques | 2 | 2015 | 1667 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2021 | 1836 | 0.030 |
Why?
|
Th17 Cells | 1 | 2023 | 791 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14752 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 13021 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2492 | 0.030 |
Why?
|
Survival Rate | 1 | 2009 | 12873 | 0.030 |
Why?
|
Superoxide Dismutase | 2 | 2009 | 595 | 0.030 |
Why?
|
Sheep, Domestic | 1 | 2015 | 52 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2011 | 4064 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 54962 | 0.030 |
Why?
|
Procollagen | 1 | 2015 | 189 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2015 | 194 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2011 | 8559 | 0.030 |
Why?
|
Cell Physiological Phenomena | 1 | 2015 | 152 | 0.030 |
Why?
|
Serum | 1 | 2015 | 207 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2024 | 3713 | 0.030 |
Why?
|
Collagen Type I | 1 | 2017 | 620 | 0.030 |
Why?
|
Polyglycolic Acid | 1 | 2015 | 408 | 0.030 |
Why?
|
Biomimetic Materials | 1 | 2015 | 173 | 0.030 |
Why?
|
Bone Substitutes | 1 | 2015 | 233 | 0.030 |
Why?
|
Nanomedicine | 1 | 2015 | 292 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 11886 | 0.020 |
Why?
|
Anisotropy | 1 | 2015 | 1295 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2009 | 5196 | 0.020 |
Why?
|
Parthenogenesis | 1 | 2010 | 30 | 0.020 |
Why?
|
Extracellular Matrix Proteins | 1 | 2015 | 835 | 0.020 |
Why?
|
Skin | 1 | 2024 | 4506 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 18068 | 0.020 |
Why?
|
Lactic Acid | 1 | 2015 | 1140 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2683 | 0.020 |
Why?
|
Cattle | 1 | 2015 | 3819 | 0.020 |
Why?
|
Osteoblasts | 1 | 2015 | 1153 | 0.020 |
Why?
|
Pigmentation | 1 | 2009 | 143 | 0.020 |
Why?
|
Mitochondria | 1 | 2022 | 3682 | 0.020 |
Why?
|
Prognosis | 1 | 2009 | 30046 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4651 | 0.020 |
Why?
|
beta 2-Microglobulin | 1 | 2009 | 330 | 0.020 |
Why?
|
Glutathione Peroxidase | 1 | 2009 | 259 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2635 | 0.020 |
Why?
|
Pregnancy | 2 | 2007 | 30265 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2009 | 449 | 0.020 |
Why?
|
Oxidoreductases | 1 | 2009 | 412 | 0.020 |
Why?
|
Cohort Studies | 1 | 2009 | 41808 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2012 | 1140 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2010 | 1793 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2007 | 705 | 0.010 |
Why?
|
Inflammation | 1 | 2024 | 10868 | 0.010 |
Why?
|
Immunoassay | 1 | 2007 | 746 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11932 | 0.010 |
Why?
|
Carotenoids | 1 | 2006 | 620 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7603 | 0.010 |
Why?
|
Young Adult | 1 | 2009 | 60131 | 0.010 |
Why?
|
Brachytherapy | 1 | 2009 | 1224 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23653 | 0.010 |
Why?
|
Child | 1 | 2009 | 80960 | 0.010 |
Why?
|
Adolescent | 1 | 2009 | 89244 | 0.010 |
Why?
|
Stem Cells | 1 | 2013 | 3539 | 0.010 |
Why?
|
Risk | 1 | 2012 | 9621 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9499 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2009 | 2909 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2007 | 3232 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2010 | 3116 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4356 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2006 | 3443 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2010 | 65480 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13674 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2009 | 39394 | 0.000 |
Why?
|
Concepts
(212)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_